Peregrine Asset Advisers’s VALEANT PHARMACEUTICALS INTL VRX Stock Holding History

Peregrine Asset Advisers’s Portfolio VRX Stock Details VRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-17,775	Closed	-$1.85M	–	176
2013 Q3	$1.85M	Buy	+17,775	New	+$1.85M	1.78%	15

Other funds holding VRX

LWI

Long Wharf Investors Boston, Massachusetts $127M AUM 18.02% 1-Year Est. Return

TWA

TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return

Peregrine Asset Advisers's VRX Position: Q4 2013 in Review

Peregrine Asset Advisers sold out of VALEANT PHARMACEUTICALS INTL (VRX) in Q4 2013, closing a stake of 17,775 shares — an estimated $1.85M sold.

Peregrine Asset Advisers first reported a position in VRX in Q3 2013 and held it in 1 quarter. The position peaked at $1.85M in Q3 2013. 2 funds tracked by Wall St. Rank hold VRX as of Q4 2013.

Peregrine Asset Advisers reported no remaining VALEANT PHARMACEUTICALS INTL position as of Q4 2013 after selling out during the quarter.
Peregrine Asset Advisers sold 17,775 VALEANT PHARMACEUTICALS INTL shares in Q4 2013, an estimated $1.85M.
Peregrine Asset Advisers first reported a position in VALEANT PHARMACEUTICALS INTL in Q3 2013 and held it in 1 quarter.
Peregrine Asset Advisers's VALEANT PHARMACEUTICALS INTL position peaked at $1.85M in Q3 2013.
2 funds tracked by Wall St. Rank held VALEANT PHARMACEUTICALS INTL as of Q4 2013.

Based on Peregrine Asset Advisers's 13F filing for Q4 2013, filed 13 Feb 2014.